Chief Medical Officer · Tonix Pharmaceuticals Holding Corp. (TNXP)

Gregory Sullivan

FY2025 is the first fiscal year CompBrief holds for Gregory Sullivan as a named executive officer of Tonix Pharmaceuticals; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,216,542

Compensation figures as of the proxy filed March 30, 2026 (DEF 14A).

Gregory Sullivan compensation by year

Tonix Pharmaceuticals Summary Compensation Table · the one fiscal year held
In US dollars, as Tonix Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$519,168
Bonus$259,600
Stock awards$0
Option awards$437,774
Non-equity incentive$0
Pension and deferred compensation$0
All other$0
Total$1,216,542

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tonix Pharmaceuticals Holding Corp. DEF 14A filed March 30, 2026, accession 0001999371-26-007108, and prior-year filings. Open the filing on EDGAR.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option29,017—$10.06
Option29,017—$8.05

Per the Outstanding Equity Awards at Fiscal Year-End table in Tonix Pharmaceuticals Holding Corp.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Tonix Pharmaceuticals’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Seth LedermanChief Executive Officer$3,168,830
Jessica MorrisChief Operations Officer$1,226,269
Gregory Sullivan · this pageChief Medical Officer$1,216,542
Bradley SaengerChief Financial Officer$1,143,513

The full Tonix Pharmaceuticals compensation record

free company brief

This page is one person within Tonix Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Tonix Pharmaceuticals's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Tonix Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy